Orexin type 1 receptor antagonist SB 334867 inhibits the central histamine-induced resuscitating effect in rats subjected to haemorrhagic shock.
Jochem
J
J
Department of Basic Medical Sciences, Medical University of Silesia, Piekarska 18, 41-902, Bytom, Poland. jjochem@poczta.onet.pl
D000818:Animals; D001583:Benzoxazoles / Q000378:metabolism*; D001794:Blood Pressure; D006339:Heart Rate; D006632:Histamine / Q000378:metabolism*; D008297:Male; D009287:Naphthyridines; D064446:Orexin Receptors; D051381:Rats; D017208:Rats, Wistar; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors* / Q000378:metabolism; D018013:Receptors, Neuropeptide / Q000037:antagonists & inhibitors* / Q000378:metabolism; D012039:Regional Blood Flow; D012151:Resuscitation; D012771:Shock, Hemorrhagic / Q000378:metabolism*; D014508:Urea / Q000031:analogs & derivatives* / Q000378:metabolism
C420062:1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea; D001583:Benzoxazoles; D009287:Naphthyridines; D064446:Orexin Receptors; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide; D006632:Histamine; D014508:Urea